Malaria vaccine candidate RTS,S reduces the risk of malaria by half in African children, study finds

First results from a large-scale Phase III trial of RTS,S* show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.